Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Public ClinicalTrials.gov record NCT00143156. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial of Pregabalin Versus Placebo in the Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy and safety of pregabalin administered twice a day compared to placebo in reducing pain in subjects with painful diabetic peripheral neuropathy.
Study identification
- NCT ID
- NCT00143156
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- May 2007 (Actual)
- Last update posted
- Jan 22, 2021
2005 – 2007
United States locations
- U.S. sites
- 53
- U.S. states
- 26
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Tuscaloosa | Alabama | 35406 | — |
| Pfizer Investigational Site | Phoenix | Arizona | 85023 | — |
| Pfizer Investigational Site | Little Rock | Arkansas | 72205 | — |
| Pfizer Investigational Site | La Mesa | California | 91942 | — |
| Pfizer Investigational Site | Los Gatos | California | 95032-3739 | — |
| Pfizer Investigational Site | Northridge | California | 91325 | — |
| Pfizer Investigational Site | Tustin | California | 92780 | — |
| Pfizer Investigational Site | Walnut Creek | California | 94598 | — |
| Pfizer Investigational Site | Boulder | Colorado | 80304 | — |
| Pfizer Investigational Site | Wheat Ridge | Colorado | 80033 | — |
| Pfizer Investigational Site | New Haven | Connecticut | 06510 | — |
| Pfizer Investigational Site | Clearwater | Florida | 33761 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021 | — |
| Pfizer Investigational Site | Ocala | Florida | 34471 | — |
| Pfizer Investigational Site | Tampa | Florida | 33606 | — |
| Pfizer Investigational Site | West Palm Beach | Florida | 33407-2450 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30303 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30309 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30327 | — |
| Pfizer Investigational Site | Decatur | Georgia | 30033 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60610 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60612 | — |
| Pfizer Investigational Site | Peoria | Illinois | 61602 | — |
| Pfizer Investigational Site | Springfield | Illinois | 62704 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46250 | — |
| Pfizer Investigational Site | Lexington | Kentucky | 40503 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21204 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02115 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02215 | — |
| Pfizer Investigational Site | Springfield | Massachusetts | 01104 | — |
| Pfizer Investigational Site | Jackson | Mississippi | 39202 | — |
| Pfizer Investigational Site | Tupelo | Mississippi | 38803-4087 | — |
| Pfizer Investigational Site | Jefferson City | Missouri | 65109 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63141 | — |
| Pfizer Investigational Site | Omaha | Nebraska | 68116-6465 | — |
| Pfizer Investigational Site | Englewood | New Jersey | 07631 | — |
| Pfizer Investigational Site | Shrewsbury | New Jersey | 07702 | — |
| Pfizer Investigational Site | New Hyde Park | New York | 11042 | — |
| Pfizer Investigational Site | New York | New York | 10022-1009 | — |
| Pfizer Investigational Site | New York | New York | 10032 | — |
| Pfizer Investigational Site | Kettering | Ohio | 45429 | — |
| Pfizer Investigational Site | Toledo | Ohio | 43623 | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | 74104-5428 | — |
| Pfizer Investigational Site | Warwick | Rhode Island | 02886 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38119 | — |
| Pfizer Investigational Site | Dallas | Texas | 75390-8858 | — |
| Pfizer Investigational Site | Frisco | Texas | 75034 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78207 | — |
| Pfizer Investigational Site | San Antonio | Texas | 78229 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84108 | — |
| Pfizer Investigational Site | Burlington | Vermont | 05401 | — |
| Pfizer Investigational Site | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00143156, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 22, 2021 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00143156 live on ClinicalTrials.gov.